BOOK ONLINE

Please select the service you would like to book:

search-button

33%  rise in domestic violence reports under COVID-19 lockdown

Press releases  •  1 June 2020  • 5 min read

Share






Copied


MSI Reproductive Choices sees a 33%  rise in domestic violence reports under COVID-19 lockdown

Overall safeguarding concerns have increased by 20%, warns the charity.

We have seen a 33% increase in domestic violence reports, as the unprecedented lockdown restrictions force women to isolate with their abusers.

These figures form part of a 20%  increase in overall safeguarding concerns during the first two months of lockdown, as calls to the MSI Reproductive Choices advice line spike.
 
Other increases include women clients under the age of 18 (10%) and women who are experiencing mental health problems (7%). 

The team at MSI Reproductive Choices UK’s contact centre, which includes dedicated safeguarding nurses for adults and children as well as ex-police support workers, are trained to spot vulnerable callers, and work with the NHS, social workers and the police amongst others, to help keep women safe while they make the choices that are right for them.

Safeguarding adults and children at MSI Reproductive Choices

The team have been a critical part of major safeguarding cases, including identifying a human trafficking ring resulting in the rescue of a number of trafficked women.  

Amy Bucknall, Named Nurse for Safeguarding of Adults and Children for MSI Reproductive Choices, said:

It is an incredibly scary time for women who need to access abortion care during COVID-19 and we’re seeing an increase in cases where women need extra safeguarding protection.

In one case, a 19-year-old girl disclosed that if her family found out that she was pregnant outside of marriage, significant harm would come to her. But as she was isolating with her family, it was incredibly difficult for her to leave the house. We had to work closely with protective agencies to get her the support she needed in order to make her choice.  

Our strong safeguarding processes are therefore critical in ensuring that vulnerable women can access the care they need in a timely manner, free from coercion and harm from others.

Over the last two months, calls to the MSI Reproductive Choices advice line have risen by more than 3500 to almost 45,000, possibly due to the large numbers of women struggling to access contraception during the coronavirus pandemic and the fact that most Clinical Commissioning Groups (CCGs) are now allowing women to select the provider with the shortest waiting times. The charity is also taking on additional caseload from NHS trusts, who have suspended their work to focus on COVID-19.

Safeguarding these women has become even more complex during the crisis, with public services stretched to the limit and normal safeguarding procedures, such as social workers accompanying clients to clinics, disrupted.

Women are also unable to lean on their usual support networks, leave their houses for extended periods of time or even access public transport if they do need to travel, exacerbating already existing vulnerabilities. 

Jonathan Lord, Medical Director for MSI Reproductive Choices UK, said:

“Controlling pregnancy and access to contraception is a method of control widely used by perpetrators of domestic abuse. In the long-term, we worry that women will be forced to continue pregnancies they do not want to keep, as abuse prevents them from accessing essential healthcare services during lockdown. 

“This will have significant long-term consequences for already vulnerable women, making it even harder for them to avoid ongoing abuse.”

The introduction of telemedicine, which enables women seeking an early medical abortion to take both sets of abortion pills at home, means some vulnerable women, including those with a coercive partner, are now able to access care more discretely. 
MSI Reproductive Choices have found safeguarding by telephone to be highly effective as women and girls who are too frightened to attend consultations in person can talk more openly and privately over the phone. They have identified some major safeguarding cases through confidential phone calls, including harrowing cases such as a 12-year-old being subject to rape by two relatives.

However, other women still need to attend clinics, especially if they have contacted MSI Reproductive Choices later in their pregnancies. Here, shockingly, they can sometimes still be subject to abuse from anti-choice groups, who despite strict social distancing measures, are still harassing women outside of Marie Stopes’ clinics. 

Shanaaz Mohammed, clinical team leader at MSI Reproductive Choices’s Central London clinic, said: 

“Unbelievably, since lockdown began, anti-choice individuals and groups have continued to gather outside our clinics, completely ignoring social distancing rules implemented by the government and essentially being a law unto themselves. We have had to call the police on two occasions due to the anti-choice group singing hymns and chanting loudly.

“This means that not only are women struggling with the impacts of COVID-19 and the complexity of accessing care during the pandemic, but they are also facing abuse and harassment when they do attend clinics. It’s horribly unfair and particularly distressing for women who may already be vulnerable.”

For further information and interviews please contact:

Email: [email protected]

Telephone: +44(0)7769166516


Share






Copied

Related posts

News


22 June 2023  • 4 min read

MSI Comment on Abortion Statistics for England and Wales: January to June 2022

Our summary of the 2022 abortion statistics for England and Wales.

News


23 June 2021  • 2 min read

MSI Reproductive Choices UK statement on fitting intrauterine contraception (IUC) and pain relief

London, 23rd June 2021  Following recent coverage on the fitting of intrauterine contraception (IUC) and

News


7 February 2020  • 2 min read

Marie Stopes UK comment on contraceptive shortages

Friday 7th February 2020: If you are covering today’s press release on contraceptive and